Shujun Liu
Shujun Liu
Подтвержден адрес электронной почты в домене hi.umn.edu
Название
Процитировано
Процитировано
Год
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ...
Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007
17302007
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly …
R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009
7932009
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts
AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ...
Cell 140 (5), 652-665, 2010
5762010
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ...
Cancer cell 8 (5), 355-368, 2005
5282005
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
W Blum, R Garzon, RB Klisovic, S Schwind, A Walker, S Geyer, S Liu, ...
Proceedings of the National Academy of Sciences 107 (16), 7473-7478, 2010
5182010
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic, M Moran, TS Lin, ...
Blood 105 (3), 959-967, 2005
4562005
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ...
The Journal of clinical investigation 117 (9), 2408-2421, 2007
3762007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
W Blum, RB Klisovic, B Hackanson, Z Liu, S Liu, H Devine, ...
Journal of Clinical Oncology 25 (25), 3884-3891, 2007
3442007
Curcumin is a potent DNA hypomethylation agent
Z Liu, Z Xie, W Jones, RE Pavlovicz, S Liu, J Yu, P Li, J Lin, JR Fuchs, ...
Bioorganic & medicinal chemistry letters 19 (3), 706-709, 2009
3012009
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
L Yu, C Liu, J Vandeusen, B Becknell, Z Dai, YZ Wu, A Raval, TH Liu, ...
Nature genetics 37 (3), 265, 2005
2802005
Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, ...
Cancer cell 17 (4), 333-347, 2010
2602010
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets
J Yu, HC Mao, M Wei, T Hughes, J Zhang, I Park, S Liu, S McClory, ...
Blood, The Journal of the American Society of Hematology 115 (2), 274-281, 2010
2502010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
S Schwind, K Maharry, MD Radmacher, K Mrózek, KB Holland, ...
Journal of clinical oncology 28 (36), 5257, 2010
1982010
Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells
J Yu, M Wei, B Becknell, R Trotta, S Liu, Z Boyd, MS Jaung, BW Blaser, ...
Immunity 24 (5), 575-590, 2006
1952006
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted …
SP Whitman, S Liu, T Vukosavljevic, LJ Rush, L Yu, C Liu, MI Klisovic, ...
Blood 106 (1), 345-352, 2005
1662005
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia
S Liu, T Shen, L Huynh, MI Klisovic, LJ Rush, JL Ford, J Yu, B Becknell, ...
Cancer research 65 (4), 1277-1284, 2005
1602005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
G Marcucci, W Stock, G Dai, RB Klisovic, S Liu, MI Klisovic, W Blum, ...
Journal of Clinical Oncology 23 (15), 3404-3411, 2005
1602005
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-κB–dependent DNA methyltransferase activity in acute myeloid leukemia
S Liu, Z Liu, Z Xie, J Pang, J Yu, E Lehmann, L Huynh, T Vukosavljevic, ...
Blood, The Journal of the American Society of Hematology 111 (4), 2364-2373, 2008
1462008
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation
A Mishra, S Liu, GH Sams, DP Curphey, R Santhanam, LJ Rush, ...
Cancer cell 22 (5), 645-655, 2012
1402012
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations
AM Dorrance, S Liu, W Yuan, B Becknell, KJ Arnoczky, M Guimond, ...
The Journal of clinical investigation 116 (10), 2707-2716, 2006
1372006
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20